Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitorsDerek J Denhart, Jeffrey A Deskus, Jonathan L Ditta, et al.Journal of Medicinal Chemistry|October 19, 2010
Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitorsH Dalton King, Zhaoxing Meng, Jeffrey A Deskus, et al.Nature Neuroscience|July 22, 2009
Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitizationEisuke Koya, Sam A Golden, Brandon K Harvey, et al.Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitorsJeffrey A Deskus, James R Epperson, Charles P Sloan, et al.Bioorganic & Medicinal Chemistry|September 11, 2004
Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amidesJames R Epperson, Marc A Bruce, John D Catt, et al.Journal of Medicinal Chemistry|September 16, 2005
Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitorsRonald J Mattson, John D Catt, Derek J Denhart, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Aminotriazine 5-HT7 antagonistsRonald J Mattson, Derek J Denhart, John D Catt, et al.Nuclear Medicine and Biology|May 6, 2014
Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptorsNicholas J Lodge, Yu-Wen Li, Frederick T Chin, et al.Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitorH Dalton King, Derek J Denhart, Jeffrey A Deskus, et al.Journal of Medicinal Chemistry|June 26, 2009
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonistsRichard A Hartz, Vijay T Ahuja, Maria Rafalski, et al.Pageof 11